Reul; Regina
Patent Applications and Registrations
Patent applications and USPTO patent grants for Reul; Regina.The latest application filed is for "solid pharmaceutical compositions for treating hcv".
- Reul; Regina - Mannheim DE
- REUL; Regina - Ludwigshafen DE
| Patent | Date |
|---|---|
| Solid pharmaceutical compositions for treating HCV Grant 11,246,866 - Sever , et al. February 15, 2 | 2022-02-15 |
| Solid Pharmaceutical Compositions for Treating HCV App 20200282004 - Sever; Nancy E. ; et al. | 2020-09-10 |
| Solid Pharmaceutical Compositions for Treating HCV App 20200253968 - Kind Code | 2020-08-13 |
| Solid Pharmaceutical Compositions for Treating HCV App 20190216882 - Sever; Nancy E. ; et al. | 2019-07-18 |
| Highly Drug-loaded Poly(alkyl 2-cyanoacrylate) Nanocapsules App 20170189344 - CURIC; Anamarija ; et al. | 2017-07-06 |
| Solid Pharmaceutical Compositions for Treating HCV App 20160375087 - Sever; Nancy E. ; et al. | 2016-12-29 |
| Solid Pharmaceutical Compositions for Treating HCV App 20160375017 - Asmus; Katharina ; et al. | 2016-12-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 